Toward next-generation advanced therapies: extracellular vesicles and cell therapy - partners or competitors?

Regen Med. 2021 Mar;16(3):215-218. doi: 10.2217/rme-2020-0138. Epub 2021 Feb 24.

Timo Z Nazari-Shafti^{1

2

3}, Sebastian Neuber^{1

2

3}, Volkmar Falk^{1

2

4

5}, Maximilian Y Emmert^{1

2

3

6

7}

¹ Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, 13353 Berlin, Germany.
² German Centre for Cardiovascular Research, Partner Site Berlin, 13353 Berlin, Germany.
³ Berlin Institute of Health Center for Regenerative Therapies, Charité - Universitätsmedizin Berlin, 13353 Berlin, Germany.
⁴ Department of Health Sciences and Technology, ETH Zürich, 8093 Zürich, Switzerland.
⁵ Clinic for Cardiovascular Surgery, Charité - Universitätsmedizin Berlin, 13353 Berlin, Germany.
⁶ Institute for Regenerative Medicine, University of Zürich, 8044 Zürich, Switzerland.
⁷ Wyss Zürich, University of Zürich and ETH Zürich, 8092 Zürich, Switzerland.

No abstract available

Keywords: advanced therapy medicinal products; cell therapy; extracellular vesicles; next-generation advanced therapy.

Publication types